Join us for Part 2 of our discussion with Craig Lipset, former Head of Clinical Innovation for Pfizer, about contingency plans for clinical trials amidst the unexpected disruption of COVID-19. In this session, Craig will walk us through some of the resources he compiled to help support remote trials and we'll give our commentary about their impact on the patient experience.
ADDITIONAL INFO
When:
Wednesday, May 13, 2020 · 12:00 p.m.
Eastern Time (US & Canada)
Jen Horonjeff, PhD, is the founder and CEO of Savvy Cooperative, as well as an autoimmune disease patient and brain tumor survivor. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine, alongside Elon Musk, Chance...
Craig Lipset is a recognized leader at the forefront of innovation in clinical research and medicine development. He is an advisor to technology and biopharmaceutical companies, leading universities, and the venture community, bringing vision and...